| Bio Roundup: Grail Acquisition, Libra’s Launch, Tau Trial Results & More | Frank Vinluan | 09/25/20 | National |
| Bio Roundup: COVID-19 Pact, Gavreto Approval, Generative Biology & More | Frank Vinluan | 09/11/20 | National |
| Now Closer to Clinical Trials, Codiak BioSciences Refiles IPO Plans | Frank Vinluan | 09/10/20 | Boston |
| Generate Bio Aims to Reveal Nature’s Protein Secrets, Create New Drugs | Frank Vinluan | 09/10/20 | Boston |
| Omega Therapeutics Lands $85M to Tap Into “Control Room” of Biology | Frank Vinluan | 07/29/20 | Boston |
| Bio Roundup: Moderna Publishes, Life Science Cash, AdComm Votes & More | Frank Vinluan | 07/17/20 | National |
| Sarepta Inks Codiak Deal to Explore Combining Exosomes, Muscle Meds | Sarah de Crescenzo | 06/22/20 | Boston |
| Bio Roundup: Biotech Billions, COVID-19 R&D, Zolgensma’s Path & More | Sarah de Crescenzo | 04/03/20 | National |
| Flagship Adds $1.1B for New Meds, More AI, & “Health Security” | Sarah de Crescenzo | 04/02/20 | National |
| Bio Roundup: Pandemic Declared, Rubius Restarts, Kymera’s Cash & More | Frank Vinluan | 03/13/20 | National |
| Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More | Frank Vinluan | 01/31/20 | National |
| Flagship Adds Fertility-Focused Ohana Biosciences to Biotech Family | Sarah de Crescenzo | 01/27/20 | Boston |
| Bio Roundup: Amarin’s Approval, FTC v. Illumina, a $120M Deal & More | Sarah de Crescenzo | 12/20/19 | National |
| Ring Therapeutics Launches to Expand Gene Therapy Viral Vector Options | Sarah de Crescenzo | 12/19/19 | Boston |
| Bio Roundup: Sarepta’s Approval, Merck M&A, Drug Price Bill & More | Frank Vinluan | 12/13/19 | National |
| Biotech Roundup: Gottlieb v. Juul, Solid Slumps, Avidity Gets $100M & More | Sarah de Crescenzo | 11/15/19 | National |
| With $65M, Cygnal Tunes In to Nerve Signals for Drug-Making Clues | Frank Vinluan | 10/08/19 | Boston |
| Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further | Ben Fidler | 09/23/19 | Boston |
| Inari Reaps $89M and Eyes Global Farm Markets for Gene-Edited Seeds | Frank Vinluan | 08/06/19 | Boston |
| The Finalists for the 2019 Xconomy Awards Are … | Angela Shah | 07/10/19 | Boston |
| Xconomy Awards: Gilman & Bosley to Emcee Life Science Gala in Boston | Angela Shah | 06/20/19 | Boston |
| Two Days, Five Biotech IPOs, and $359M Raised for Clinical Trials | Frank Vinluan | 05/09/19 | National |
| Exosomes Head to Wall Street As Codiak Biosciences Lines Up IPO | Ben Fidler | 04/30/19 | Boston |
| Flagship Pioneering Unveils Kintai’s Gut Approach to Treating Disease | Frank Vinluan | 04/16/19 | Boston |
| Flagship Reloads With $824M For Latest Growth Capital Fund | Ben Fidler | 03/20/19 | Boston |
| Seres Lays Off 30% of Staff, CSO Leaves After Pipeline Review | Corie Lok | 02/07/19 | Boston |
| NYCEDC Finally Puts Its NY Bio Fund to Work With $60M For HiberCell | Ben Fidler | 02/07/19 | New York |
| Kaleido Bio and Cirius Join an IPO Queue Stalled by Federal Shutdown | Frank Vinluan | 01/11/19 | Boston |
| Moderna Raises $604M and Nails Down Biotech’s Biggest IPO Ever | Ben Fidler | 12/06/18 | Boston |
| With CRISPR’s Help, KSQ Touts 13 Cancer Drugs and Bags Another $80M | Ben Fidler | 09/28/18 | Boston |
